Who are Ra Pharmaceuticals's investors?

Ra Pharmaceuticals's investors include Lightstone Ventures, RA Capital Management, Novo Holdings A/S, Novartis Venture Fund, Amgen, NEA.

When was Ra Pharmaceuticals founded?

Ra Pharmaceuticals was founded in 2008.

Where is Ra Pharmaceuticals headquartered?

Ra Pharmaceuticals is headquartered in Cambridge, Massachusetts, United States.

What industry is Ra Pharmaceuticals in?

Ra Pharmaceuticals operates in Biotech, Drug Discovery.

How many employees does Ra Pharmaceuticals have?

Ra Pharmaceuticals has 51-200 employees.

Ra Pharmaceuticals

Acquired

Cambridge, United States · Founded 2008

Biotech

Drug Discovery

Headquarters: Cambridge, Massachusetts
Employees: 51–200
Founded: 2008
Business Model: B2B

Website: rapharma.com
Last Round: Series BJul 2015
Rounds: 3

About

Ra Pharmaceuticals was a Cambridge, Massachusetts-based clinical-stage biopharmaceutical company focused on discovering and developing novel therapeutics targeting the complement system to treat rare and severe diseases. The company's lead asset zilucoplan targeted generalized myasthenia gravis. Ra Pharmaceuticals was acquired by UCB for approximately $2.1 billion in April 2020.

Summary

Ra Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2008. Its most recent funding was a Series B round in Jul 2015. Investors include Lightstone Ventures, RA Capital Management and Novo Holdings A/S.